| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q4 2023 | 92 | 117,077 | AUGX, LLY, IDXX, MSFT | 13F-HR | 1/22/2024 | 000088430024000001 |
| Q3 2023 | 98 | 100,871 | AUGX, LLY, MSFT, IDXX | 13F-HR | 11/2/2023 | 000088430023000007 |
| Q2 2023 | 97 | 114,754 | AUGX, LLY, IDXX, MSFT | 13F-HR | 7/21/2023 | 000088430023000006 |
| Q1 2023 | 97 | 106,059 | IDXX, LLY, MSFT, PERI | 13F-HR | 5/9/2023 | 000088430023000004 |
| Q4 2022 | 100 | 94,726 | LLY, IDXX, DGII, MSFT | 13F-HR | 1/26/2023 | 000088430023000001 |
| Q3 2022 | 104 | 89,370 | LLY, DGII, AXGN, MSFT | 13F-HR | 10/24/2022 | 000088430022000004 |
| Q2 2022 | 105 | 96,606 | LLY, MSFT, IDXX, ABT | 13F-HR | 7/29/2022 | 000088430022000003 |
| Q1 2022 | 110 | 121,984 | IDXX, MSFT, OPRX, LLY | 13F-HR | 4/20/2022 | 000088430022000002 |
| Q4 2021 | 109 | 148,128 | IDXX, OPRX, NTRA, NEO | 13F-HR | 2/10/2022 | 000088430022000001 |
| Q3 2021 | 106 | 161,533 | OPRX, NEO, NTRA, IDXX | 13F-HR | 10/25/2021 | 000088430021000005 |
| Q2 2021 | 106 | 176,228 | CDNA, OPRX, NEO, NTRA | 13F-HR | 7/28/2021 | 000088430021000004 |
| Q1 2021 | 105 | 172,924 | VCEL, NEO, CDNA, VCYT | 13F-HR | 4/28/2021 | 000088430021000003 |
| Q4 2020 | 100 | 152,905 | NEO, VCEL, CDNA, NTRA | 13F-HR | 2/9/2021 | 000088430021000001 |
| Q3 2020 | 93 | 108,878 | NEO, VCEL, NTRA, CDNA | 13F-HR | 10/28/2020 | 000088430020000006 |
| Q1 2020 | 107 | 82,778 | NEO, VCEL, AXGN, VCYT | 13F-HR | 4/29/2020 | 000088430020000004 |
| Q4 2019 | 112 | 111,549 | NEO, VCEL, AXGN, VCYT | 13F-HR | 2/3/2020 | 000088430020000001 |
| Q3 2019 | 112 | 116,060 | VCEL, NEO, AXGN, NTRA | 13F-HR | 10/23/2019 | 000088430019000009 |
| Q2 2019 | 110 | 142,800 | VCEL, AXGN, NEO, VCYT | 13F-HR | 8/9/2019 | 000088430019000008 |
| Q1 2019 | 124 | 151,878 | VCEL, AXGN, PARETEUM CORP, NEO | 13F-HR | 4/22/2019 | 000088430019000007 |
| Q4 2018 | 126 | 128,964 | VCEL, AXGN, ABT, CDNA | 13F-HR | 2/11/2019 | 000088430019000001 |
| Q3 2018 | 132 | 166,574 | AXGN, VCEL, CDNA, ABT | 13F-HR | 10/22/2018 | 000088430018000008 |
| Q2 2018 | 127 | 139,619 | AXGN, VCEL, ABT, NEO | 13F-HR | 8/2/2018 | 000088430018000007 |
| Q1 2018 | 117 | 111,068 | AXGN, VCEL, ABT, IDXX | 13F-HR | 4/23/2018 | 000088430018000006 |
| Q4 2017 | 111 | 103,996 | AXGN, ABT, VCEL, NEO | 13F-HR | 1/26/2018 | 000088430018000005 |
| Q3 2017 | 102 | 95,447 | AXGN, ABT, RMTI, NEO | 13F-HR | 10/31/2017 | 000088430017000008 |
| Q2 2017 | 106 | 90,171 | AXGN, ABT, RMTI, ATRC | 13F-HR | 7/26/2017 | 000088430017000007 |
| Q1 2017 | 111 | 96,924 | AXGN, NEO, CSII, ABT | 13F-HR | 4/19/2017 | 000088430017000006 |
| Q4 2016 | 103 | 91,212 | AXGN, STJ, NEO, CSII | 13F-HR | 2/1/2017 | 000088430017000001 |
| Q3 2016 | 112 | 100,014 | AXGN, NEO, STJ, BOVIE MEDICAL CORP | 13F-HR | 11/4/2016 | 000088430016000042 |
| Q2 2016 | 116 | 87,232 | NEO, STJ, AXGN, RMTI | 13F-HR | 7/20/2016 | 000088430016000041 |
| Q1 2016 | 117 | 79,890 | STJ, NEO, RMTI, AXGN | 13F-HR | 4/18/2016 | 000088430016000034 |
| Q4 2015 | 121 | 93,194 | STJ, NEO, RMTI, AXGN | 13F-HR | 1/28/2016 | 000088430016000022 |
| Q3 2015 | 121 | 89,881 | STJ, NEO, RMTI, AXGN | 13F-HR | 11/9/2015 | 000088430015000021 |
| Q2 2015 | 129 | 113,869 | RMTI, STJ, NEO, HILL | 13F-HR | 7/29/2015 | 000088430015000017 |
| Q1 2015 | 136 | 119,301 | STJ, RMTI, CSII, NEO | 13F-HR | 4/28/2015 | 000088430015000012 |
| Q4 2014 | 129 | 116,527 | STJ, RMTI, NEO, CSII | 13F-HR | 2/13/2015 | 000088430015000010 |
| Q3 2014 | 138 | 118,321 | STJ, RMTI, NEO, UPI | 13F-HR | 11/14/2014 | 000088430014000017 |
| Q2 2014 | 141 | 142,137 | RMTI, STJ, CSII, UPI | 13F-HR | 8/15/2014 | 000088430014000014 |
| Q1 2014 | 133 | 142,518 | RMTI, STJ, UPI, CSII | 13F-HR | 5/7/2014 | 000088430014000013 |
| Q4 2013 | 134 | 148,247 | RMTI, STJ, HILL, UPI | 13F-HR | 2/12/2014 | 000088430014000011 |